{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:43:18Z","timestamp":1787071398952,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Plasma lactate &gt;2 mmol\/L has been associated with increased mortality in acute pulmonary embolism (PE), even among hemodynamically stable patients. Despite strong evidence, lactate remains underutilized in risk stratification tools such as the simplified PE Severity Index (sPESI). To assess the incremental prognostic value of plasma lactate when integrated into a Bayesian probability model for Pulmonary Embolism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Pretest probabilities were defined by SI and sPESI. Sensitivity and specificity for plasma lactate &gt;2 mmol\/L were derived from prior meta-analyses and validated multicenter datasets. Likelihood ratios were applied within a Bayesian nomogram to estimate posttest probabilities. Diagnostic efficiency was evaluated using Bayesian Diagnostic Gain (BDG) and Bayesian Number Needed to Diagnose (BNND).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Thirty-day mortality for SI &gt;1 was 24.1% versus 10.7% for low-risk SI and 10.7% versus 1.5% for sPESI. Lactate &gt;2 mmol\/L yielded 82.4% sensitivity (95% confidence interval [CI]: 56.8\u201395.3) and 73.5% specificity (95% CI: 71.8\u201374.4). Integrating lactate into the SI model produced an Absolute Diagnostic Gain (ADG) of 25.9% (BNND = 4), outperforming the sPESI model (ADG: 16.3%, BNND = 6).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Bayesian integration of plasma lactate with the SI enhances prognostic accuracy and produces superior diagnostic gains compared with sPESI-based models. This supports a probabilistic, physiology-driven approach to PE risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijciis.ijciis_116_25","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:00:10Z","timestamp":1775646010000},"page":"67-71","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Plasma lactate and severity of illness for acute pulmonary embolism: A Bayesian probability model"],"prefix":"10.4103","volume":"16","author":[{"given":"Amado Alejandro","family":"B\u00e1ez","sequence":"first","affiliation":[{"name":"Department of Biomedical Research, Pedro Henriquez Ure\u00f1a National University, Santo Domingo, Dominican Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith","family":"Ibu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Research, Pedro Henriquez Ure\u00f1a National University, Santo Domingo, Dominican Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Halasz","sequence":"additional","affiliation":[{"name":"Department of Biomedical Research, Pedro Henriquez Ure\u00f1a National University, Santo Domingo, Dominican Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"R1-20260518","doi-asserted-by":"crossref","first-page":"10760296251366420","DOI":"10.1177\/10760296251366420","article-title":"Relationship Between the Lactate-to-Albumin Ratio and 28-Day Overall Mortality in Critically Ill Patients with Pulmonary Embolism: A Retrospective Analysis of the MIMIC-IV Database","volume":"31","author":"Xu","year":"2025","journal-title":"Clin Appl Thromb Hemost"},{"key":"R2-20260518","doi-asserted-by":"crossref","first-page":"110942","DOI":"10.1016\/j.clinbiochem.2025.110942","article-title":"Venous lactate as a tool for the risk-stratification of patients with acute pulmonary embolism: A retrospective cohort study","volume":"138","author":"Lee","year":"2025","journal-title":"Clin Biochem"},{"key":"R3-20260518","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2147\/VHRM.S488424","article-title":"Association of lactate with risk of cardiovascular diseases: A two-sample Mendelian randomization study","volume":"20","author":"Chang","year":"2024","journal-title":"Vasc Health Risk Manag"},{"key":"R4-20260518","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3892\/ol.2022.13288","article-title":"Characteristics and outcomes of cancer patients who develop pulmonary embolism: A cross-sectional study","volume":"23","author":"Chlapoutakis","year":"2022","journal-title":"Oncol Lett"},{"key":"R5-20260518","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejim.2021.03.004","article-title":"Venous lactate: The new \u201cmagic marker\u201d for stratification in intermediate-risk pulmonary embolism?","volume":"86","author":"Meneveau","year":"2021","journal-title":"Eur J Intern Med"},{"key":"R6-20260518","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejim.2021.01.021","article-title":"Venous lactate improves the prediction of in-hospital adverse outcomes in normotensive pulmonary embolism","volume":"86","author":"Ebner","year":"2021","journal-title":"Eur J Intern Med"},{"key":"R7-20260518","doi-asserted-by":"crossref","first-page":"106532","DOI":"10.1016\/j.ejim.2025.106532","article-title":"Association between sPESI score and 90-day hospital readmissions in patients with acute pulmonary embolism","volume":"142","author":"Bonsu","year":"2025","journal-title":"Eur J Intern Med"},{"key":"R8-20260518","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1002\/ehf2.15392","article-title":"Haemodynamic consequences of acute pulmonary embolism predict risk of CTPA-related acute kidney injury","volume":"12","author":"Landowska","year":"2025","journal-title":"ESC Heart Fail"},{"key":"R9-20260518","first-page":"1928","article-title":"Choosing the right tool: Comparing risk stratification models in intermediate-risk pulmonary embolism","volume":"106","author":"Zhang","year":"2025","journal-title":"Catheter Cardiovasc Interv"},{"key":"R10-20260518","first-page":"787","article-title":"Outcome of patients with different clinical presentations of high-risk pulmonary embolism","volume":"10","author":"Ebner","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"R11-20260518","first-page":"e26781","article-title":"Assessment of a comparative bayesian-enhanced population-based decision model for COVID-19 critical care prediction in the Dominican republic social security Affiliates","volume":"14","author":"Baez","year":"2022","journal-title":"Cureus"},{"key":"R12-20260518","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12911-019-1015-5","article-title":"A Bayesian decision support sequential model for severity of illness predictors and intensive care admissions in pneumonia","volume":"19","author":"Baez","year":"2019","journal-title":"BMC Med Inform Decis Mak"},{"key":"R13-20260518","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jcrc.2016.08.007","article-title":"Improved rule-out diagnostic gain with a combined aortic dissection detection risk score and D-dimer Bayesian decision support scheme","volume":"37","author":"Baez","year":"2017","journal-title":"J Crit Care"}],"container-title":["International Journal of Critical Illness and Injury Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijciis.ijciis_116_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:45:35Z","timestamp":1787067935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijciis.ijciis_116_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijciis.ijciis_116_25","relation":{},"ISSN":["2229-5151","2231-5004"],"issn-type":[{"value":"2229-5151","type":"print"},{"value":"2231-5004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2025-10-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}